Target Name: KLF3
NCBI ID: G51274
Review Report on KLF3 Target / Biomarker Content of Review Report on KLF3 Target / Biomarker
KLF3
Other Name(s): TEF-2 | BKLF | basic Kruppel-like factor | CACCC-box-binding protein BKLF | Krueppel-like factor 3 | MGC48279 | basic krueppel-like factor | Basic kruppel like factor | KLF transcription factor 3 | KLF3_HUMAN | basic kruppel like factor | Basic krueppel-like factor | Kruppel-like factor 3 (basic) | transcript ch138 | Kruppel like factor 3

KLF3: A Protein Involved in Tissue Homeostasis and Cell Survival

KLF3 (Kallikrein-related factor 3) is a protein that is expressed in various tissues throughout the body. It is a member of the serpinecralin gene family, which is known for producing structurally unique proteins that are involved in various cellular processes. One of the unique features of KLF3 is its ability to induce the production of platelet-derived growth factors (PDGFs), which are essential for the growth and maintenance of tissues.

KLF3 has been shown to play a role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its role in these processes is not well understood, but it is known that it is involved in the regulation of cellular processes that are critical for maintaining tissue homeostasis and cell survival.

One of the unique features of KLF3 is its ability to induce the production of PDGFs. PDGFs are a family of transmembrane proteins that play a critical role in the development and maintenance of tissues and organs. They are involved in a wide range of processes, including cell growth, differentiation, and angiogenesis.

In addition to its role in PDGF production, KLF3 is also known to play a role in the regulation of cellular processes that are critical for maintaining tissue homeostasis and cell survival. This includes the regulation of cell adhesion, which is the process by which cells stick together to form tissues and organs.

KLF3 has been shown to play a role in the regulation of cell adhesion by promoting the production of tight junctions, which are a type of cell-cell adhesion structure that helps to maintain the integrity of tissues. tight junctions are made up of a protein called Zonulin, which is involved in the regulation of cell-cell adhesion.

In addition to its role in cell adhesion, KLF3 is also known to play a role in the regulation of cellular processes that are critical for maintaining tissue homeostasis and cell survival. This includes the regulation of cell migration, which is the process by which cells move through tissues and organs in order to perform their functions.

KLF3 has been shown to play a role in the regulation of cell migration by promoting the production of a protein called FAK (focal adhesion kinase), which is involved in the regulation of cell-cell adhesion and migration. FAK is a protein that is involved in the regulation of many cellular processes, including cell adhesion, angiogenesis, and cancer.

In conclusion, KLF3 is a protein that is involved in a wide range of cellular processes that are critical for maintaining tissue homeostasis and cell survival. Its ability to induce the production of PDGFs and regulate cell adhesion and migration suggests that it may be a drug target or biomarker for a variety of diseases. Further research is needed to fully understand the role of KLF3 in these processes and to develop effective treatments for these diseases.

Protein Name: KLF Transcription Factor 3

Functions: Binds to the CACCC box of erythroid cell-expressed genes. May play a role in hematopoiesis (By similarity)

The "KLF3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KLF3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

KLF3-AS1 | KLF4 | KLF5 | KLF6 | KLF7 | KLF8 | KLF9 | KLHDC1 | KLHDC10 | KLHDC2 | KLHDC3 | KLHDC4 | KLHDC7A | KLHDC7B | KLHDC7B-DT | KLHDC8A | KLHDC8B | KLHDC9 | KLHL1 | KLHL10 | KLHL11 | KLHL12 | KLHL13 | KLHL14 | KLHL15 | KLHL17 | KLHL18 | KLHL2 | KLHL20 | KLHL21 | KLHL22 | KLHL23 | KLHL24 | KLHL25 | KLHL26 | KLHL28 | KLHL29 | KLHL3 | KLHL30 | KLHL30-AS1 | KLHL31 | KLHL32 | KLHL33 | KLHL34 | KLHL35 | KLHL36 | KLHL38 | KLHL4 | KLHL40 | KLHL41 | KLHL42 | KLHL5 | KLHL6 | KLHL7 | KLHL7-DT | KLHL8 | KLHL9 | KLK1 | KLK10 | KLK11 | KLK12 | KLK13 | KLK14 | KLK15 | KLK2 | KLK3 | KLK4 | KLK5 | KLK6 | KLK7 | KLK8 | KLK9 | KLKB1 | KLKP1 | KLLN | KLRA1P | KLRB1 | KLRC1 | KLRC2 | KLRC3 | KLRC4 | KLRC4-KLRK1 | KLRD1 | KLRF1 | KLRF2 | KLRG1 | KLRG2 | KLRK1 | KLRK1-AS1 | KMO | KMT2A | KMT2B | KMT2C | KMT2CP4 | KMT2D | KMT2E | KMT2E-AS1 | KMT5A | KMT5B | KMT5C